Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2014 1
2015 1
2016 3
2017 2
2019 2
2020 1
2021 5
2022 5
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide.
Matsuoka T, Sugiyama A, Miyawaki Y, Hidaka Y, Okuno Y, Sakai H, Tanaka H, Yoshikawa K, Fukui T, Mizuno K, Sumiyoshi T, Goto T, Inoue T, Akamatsu S, Kobayashi T, Nakamura E. Matsuoka T, et al. Among authors: fukui t. Cancer Sci. 2024 Jan;115(1):283-297. doi: 10.1111/cas.15984. Epub 2023 Nov 3. Cancer Sci. 2024. PMID: 37923364 Free PMC article.
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
Sekine Y, Iwasaki Y, Aoi T, Endo M, Hirata M, Kamatani Y, Matsuda K, Sugano K, Yoshida T, Murakami Y, Fukui T, Akamatsu S, Ogawa O, Nakagawa H, Numakura K, Narita S, Habuchi T, Momozawa Y. Sekine Y, et al. Among authors: fukui t. Hum Mol Genet. 2022 Jun 22;31(12):1962-1969. doi: 10.1093/hmg/ddab345. Hum Mol Genet. 2022. PMID: 35764097
A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome.
Sano T, Fukui T, Makita N, Shimizu K, Kono J, Masui K, Sato T, Goto T, Sawada A, Fujimoto M, Kojima F, Torishima M, Wada T, Furuya M, Ogawa O, Kobayashi T, Akamatsu S. Sano T, et al. Among authors: fukui t. Cancer Genet. 2022 Aug;266-267:28-32. doi: 10.1016/j.cancergen.2022.06.001. Epub 2022 Jun 5. Cancer Genet. 2022. PMID: 35691222
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.
Nishiyama N, Kobayashi T, Narita S, Hidaka Y, Ito K, Maruyama S, Mukai S, Tsutsumi M, Miki J, Okuno T, Yoshio Y, Matsumoto H, Shimazui T, Segawa T, Karashima T, Masui K, Fukuta F, Tashiro K, Imai K, Suekane S, Nagasawa S, Higashi S, Fukui T, Kojima T, Morita S, Ogawa O, Nishiyama H, Kitamura H; Japan Urological Oncology Group. Nishiyama N, et al. Among authors: fukui t. J Geriatr Oncol. 2022 Jan;13(1):88-93. doi: 10.1016/j.jgo.2021.07.002. Epub 2021 Jul 6. J Geriatr Oncol. 2022. PMID: 34238726
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.
Kobayashi T, Ito K, Kojima T, Maruyama S, Mukai S, Tsutsumi M, Miki J, Okuno T, Yoshio Y, Matsumoto H, Shimazui T, Segawa T, Karashima T, Masui K, Fukuta F, Tashiro K, Imai K, Suekane S, Nagasawa S, Higashi S, Fukui T, Ogawa O, Kitamura H, Nishiyama H. Kobayashi T, et al. Among authors: fukui t. Cancer Immunol Immunother. 2022 Feb;71(2):461-471. doi: 10.1007/s00262-021-03000-8. Epub 2021 Jul 7. Cancer Immunol Immunother. 2022. PMID: 34235546 Free PMC article.
Thymic cancer mimicking a metastasis of testicular seminoma.
Fukui T, Terada N, Takeda M, Inoue T, Kamba T, Yoshimura K, Chen F, Ogawa O. Fukui T, et al. Int Cancer Conf J. 2015 May 10;5(1):45-47. doi: 10.1007/s13691-015-0223-9. eCollection 2016 Jan. Int Cancer Conf J. 2015. PMID: 31149422 Free PMC article.
Single-Gate MoS2 Tunnel FET with a Thickness-Modulated Homojunction.
Fukui T, Nishimura T, Miyata Y, Ueno K, Taniguchi T, Watanabe K, Nagashio K. Fukui T, et al. ACS Appl Mater Interfaces. 2024 Feb 21;16(7):8993-9001. doi: 10.1021/acsami.3c15535. Epub 2024 Feb 7. ACS Appl Mater Interfaces. 2024. PMID: 38324211
Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model.
Takeda M, Sakamoto H, Shibasaki N, Fukui T, Magaribuchi T, Sumiyoshi T, Utsunomiya N, Sawada A, Goto T, Kobayashi T, Ueda K, Yamasaki T, Ogawa O, Akamatsu S. Takeda M, et al. Among authors: fukui t. Front Oncol. 2023 Mar 23;13:1139049. doi: 10.3389/fonc.2023.1139049. eCollection 2023. Front Oncol. 2023. PMID: 37064121 Free PMC article.
23 results